Current Understating of Gut Microbiome Alterations and Therapeutic Approaches for Improving Human Health
Abstract
Millions of microorganisms, including bacteria, fungi, and viruses compose the human gut microbiome. There is variation in the composition of species from the moment of birth throughout the whole human lifecycle. Gut microbiome play a central role in maintaining body equilibrium, influencing a range of physiological processes including metabolism, the maintenance of barriers, inflammation, and hematopoiesis, both within and outside the intestines. An imbalanced microbial environment within the gastrointestinal tract is at the core of numerous diseases, such as inflammatory bowel disorder, obesity, diabetes, and Clostridioides difficile infection, and plays a pivotal role in their development. In this review, we discuss the therapeutic approaches of gut microbiome-related therapies including fecal microbiota transplantation, anti-microbial therapies, prebiotics, probiotics and Dietary interventions to repair the altered gut microbiome composition. The pursuit of new therapies and their subsequent improvement is propelled by an ongoing requirement for evaluation, experimentation, laboratory procedures, and the ethical and technological limitations associated with clinical translation.
References
Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., & Aadil, R. M. (2022). Human gut microbiota in health and disease: Unveiling the relationship. Frontiers in Microbiology, 13, 999001. https://doi.org/10.3389/fmicb.2022.999001
Banerjee, A., Somasundaram, I., Das, D., Jain Manoj, S., Banu, H., Mitta Suresh, P., Paul, S., Bisgin, A., Zhang, H., Sun, X.-F., Duttaroy, A. K., & Pathak, S. (2023). Functional Foods: A Promising Strategy for Restoring Gut Microbiota Diversity Impacted by SARS-CoV-2 Variants. Nutrients, 15(11), 2631. https://doi.org/10.3390/nu15112631
Bear, T.L.K., Dalziel, J.E., Coad, J., Roy, N.C., Butts, C.A. and Gopal, P.K. (2020). The Role of the Gut Microbiota in Dietary Interventions for Depression and Anxiety. Advances in Nutrition, 11(4), 890–907. https://doi.org/10.1093/advances/nmaa016
Bhalodi, A. A., van Engelen, T. S. R., Virk, H. S., & Wiersinga, W. J. (2019). Impact of antimicrobial therapy on the gut microbiome. Journal of Antimicrobial Chemotherapy, 74(Supplement_1), i6–i15. https://doi.org/10.1093/jac/dky530
Brandt, L. J. (2013). American Journal of Gastroenterology Lecture: Intestinal Microbiota and the Role of Fecal Microbiota Transplant (FMT) in Treatment of C. difficile Infection. American Journal of Gastroenterology, 108(2), 177–185. https://doi.org/10.1038/ajg.2012.450
Bull, M. J., & Plummer, N. T. (2014). Part 1: The Human Gut Microbiome in Health and Disease. Integrative Medicine (Encinitas, Calif.), 13(6), 17–22. http://www.ncbi.nlm.nih.gov/pubmed/26770121
Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., Li, H., Alekseyenko, A. V., & Blaser, M. J. (2012). Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature, 488(7413), 621–626. https://doi.org/10.1038/nature11400
Choo, J. M., Kanno, T., Zain, N. M. M., Leong, L. E. X., Abell, G. C. J., Keeble, J. E., Bruce, K. D., Mason, A. J., & Rogers, G. B. (2017). Divergent Relationships between Fecal Microbiota and Metabolome following Distinct Antibiotic-Induced Disruptions. mSphere, 2(1), e00005-17. https://doi.org/10.1128/mSphere.00005-17
Colman, R. J., & Rubin, D. T. (2014). Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis. Journal of Crohn’s and Colitis, 8(12), 1569–1581. https://doi.org/10.1016/j.crohns.2014.08.006
Colombel, J. F. (2014). IBD—genes, bacteria and new therapeutic strategies. Nature Reviews Gastroenterology & Hepatology, 11(11), 652–654. https://doi.org/10.1038/nrgastro.2014.170
Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., Mohkam, M., Masoumi, S., Berenjian, A., & Ghasemi, Y. (2019). Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods, 8(3), 92.
https://doi.org/10.3390/foods8030092
De Filippis, F., Vitaglione, P., Cuomo, R., Berni Canani, R. and Ercolini, D. (2018). Dietary Interventions to Modulate the Gut Microbiome—How Far Away Are We from Precision Medicine. Inflammatory Bowel Diseases, 24(10), 2142–2154. https://doi.org/10.1093/ibd/izy080.
Depommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., Falony, G., Raes, J., Maiter, D., Delzenne, N. M., de Barsy, M., Loumaye, A., Hermans, M. P., Thissen, J.P., de Vos, W. M., & Cani, P. D. (2019). Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine, 25(7), 1096–1103. https://doi.org/10.1038/s41591-019-0495-2
Dubberke, E. R., Mullane, K. M., Gerding, D. N., Lee, C. H., Louie, T. J., Guthertz, H., & Jones, C. (2016). Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection. Open Forum Infectious Diseases, 3(3). https://doi.org/10.1093/ofid/ofw133
Farias, D. de P., de Araújo, F.F., Neri-Numa, I.A. and Pastore, G.M. (2019). Prebiotics: Trends in food, health and technological applications. Trends in Food Science & Technology, 93, 23–35. https://doi.org/10.1016/j.tifs.2019.09.004.
Fernández, J., Ledesma, E., Monte, J., Millán, E., Costa, P., de la Fuente, V. G., García, M. T. F., Martínez-Camblor, P., Villar, C. J., & Lombó, F. (2019). Traditional Processed Meat Products Re-designed Towards Inulin-rich Functional Foods Reduce Polyps in Two Colorectal Cancer Animal Models. Scientific Reports, 9(1), 14783. https://doi.org/10.1038/s41598-019-51437-w
Fidelis, M., Santos, J. S., Escher, G. B., Rocha, R. S., Cruz, A. G., Cruz, T. M., Marques, M. B., Nunes, J. B., do Carmo, M. A. V., de Almeida, L. A., Kaneshima, T., Azevedo, L., & Granato, D. (2021). Polyphenols of jabuticaba [Myrciaria jaboticaba (Vell.) O.Berg] seeds incorporated in a yogurt model exert antioxidant activity and modulate gut microbiota of 1,2-dimethylhydrazine-induced colon cancer in rats. Food Chemistry, 334, 127565. https://doi.org/10.1016/j.foodchem.2020.127565
Gibson, G. R., & Roberfroid, M. B. (1995). Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics. The Journal of Nutrition, 125(6), 1401–1412. https://doi.org/10.1093/jn/125.6.1401
Gibson, P.R., & Shepherd, S.J. (2005). Personal view: food for thought - western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis. Alimentary Pharmacology and Therapeutics, [online] 21(12), pp.1399–1409. https://doi.org/10.1111/j.1365-2036.2005.02506.x.
Giedraitienė, A., Vitkauskienė, A., Naginienė, R., & Pavilonis, A. (2011). Antibiotic Resistance Mechanisms of Clinically Important Bacteria. Medicina, 47(3), 19. https://doi.org/10.3390/medicina47030019
Gulliver, E. L., Young, R. B., Chonwerawong, M., D’Adamo, G. L., Thomason, T., Widdop, J. T., Rutten, E. L., Rossetto Marcelino, V., Bryant, R. V., Costello, S. P., O’Brien, C. L., Hold, G. L., Giles, E. M., & Forster, S. C. (2022). Review article: the future of microbiome‐based therapeutics. Alimentary Pharmacology & Therapeutics, 56(2), 192–208. https://doi.org/10.1111/apt.17049
Gupta, A., & Khanna, S. (2017). Fecal Microbiota Transplantation. JAMA, 318(1), 102. https://doi.org/10.1001/jama.2017.6466
Gupta, A., Saha, S., & Khanna, S. (2020). Therapies to modulate gut microbiota: Past, present and future. World Journal of Gastroenterology, 26(8), 777–788. https://doi.org/10.3748/wjg.v26.i8.777
Hemarajata, P., & Versalovic, J. (2013). Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therapeutic Advances in Gastroenterology, 6(1), 39–51. https://doi.org/10.1177/1756283X12459294
Hernando-Amado, S., Coque, T. M., Baquero, F., & Martínez, J. L. (2019). Defining and combating antibiotic resistance from One Health and Global Health perspectives. Nature Microbiology, 4(9), 1432–1442. https://doi.org/10.1038/s41564-019-0503-9
Iqbal, Z., Ahmed, S., Tabassum, N., Bhattacharya, R., & Bose, D. (2021). Role of probiotics in prevention and treatment of enteric infections: a comprehensive review. 3 Biotech, 11(5), 242. https://doi.org/10.1007/s13205-021-02796-7
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013). Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis. American Journal of Gastroenterology, 108(4), 500–508. https://doi.org/10.1038/ajg.2013.59
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007). The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects. Gastroenterology, 133(1), 24–33. https://doi.org/10.1053/j.gastro.2007.04.005
Khanna, S. (2018). Microbiota Replacement Therapies: Innovation in Gastrointestinal Care. Clinical Pharmacology & Therapeutics, 103(1), 102–111. https://doi.org/10.1002/cpt.923
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018). Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proceedings of the National Academy of Sciences, 115(15). https://doi.org/10.1073/pnas.1717295115
Kosnicki, K. L., Penprase, J. C., Cintora, P., Torres, P. J., Harris, G. L., Brasser, S. M., & Kelley, S. T. (2019). Effects of moderate, voluntary ethanol consumption on the rat and human gut microbiome. Addiction Biology, 24(4), 617–630. https://doi.org/10.1111/adb.12626
Lamichhane, S., Sen, P., Dickens, A. M., Orešič, M., & Bertram, H. C. (2018). Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe. Methods, 149, 3–12. https://doi.org/10.1016/j.ymeth.2018.04.029
Lee, D., Baldassano, R.N., Otley, A.R., Albenberg, L., Griffiths, A.M., Compher, C., Chen, E.Z., Li, H., Gilroy, E., Nessel, L., Grant, A., Chehoud, C., Bushman, F.D., Wu, G.D. and Lewis, J.D. (2015). Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohnʼs Disease. Inflammatory Bowel Diseases, 21(8), 1786–1793. https://doi.org/10.1097/mib.0000000000000426.
Lindefeldt, M., Eng, A., Darban, H., Bjerkner, A., Zetterström, C. K., Allander, T., Andersson, B., Borenstein, E., Dahlin, M., & Prast-Nielsen, S. (2019). The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy. Npj Biofilms and Microbiomes, 5(1), 5. https://doi.org/10.1038/s41522-018-0073-2
Looft, T., Johnson, T. A., Allen, H. K., Bayles, D. O., Alt, D. P., Stedtfeld, R. D., Sul, W. J., Stedtfeld, T. M., Chai, B., Cole, J. R., Hashsham, S. A., Tiedje, J. M., & Stanton, T. B. (2012). In-feed antibiotic effects on the swine intestinal microbiome. Proceedings of the National Academy of Sciences, 109(5), 1691–1696. https://doi.org/10.1073/pnas.1120238109
Markowiak, P., & Śliżewska, K. (2017). Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients, 9(9), 1021. https://doi.org/10.3390/nu9091021
Martinez, S., Campa, A., Narasimhan, G., Portuando, D., Seminario, L., Jasmin, J., & Baum, M. (2019). Pilot Study on the Effect of Cocaine Use on the Intestinal Microbiome and Metabolome and Inflammation in HIV-Infected Adults in the Miami Adult Studies in HIV (MASH) Cohort (P13-027-19). Current Developments in Nutrition, 3, nzz036.P13-027-19. https://doi.org/10.1093/cdn/nzz036.P13-027-19
Oniszczuk, A., Oniszczuk, T., Gancarz, M., & Szymańska, J. (2021). Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases. Molecules, 26(4), 1172. https://doi.org/10.3390/molecules26041172
Palleja, A., Mikkelsen, K. H., Forslund, S. K., Kashani, A., Allin, K. H., Nielsen, T., Hansen, T. H., Liang, S., Feng, Q., Zhang, C., Pyl, P. T., Coelho, L. P., Yang, H., Wang, J., Typas, A., Nielsen, M. F., Nielsen, H. B., Bork, P., Wang, J., Vilsbøll, T., Hansen, T., Knop, F. K., Arumugam, M. & Pedersen, O. (2018). Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology, 3(11), 1255–1265. https://doi.org/10.1038/s41564-018-0257-9
Panda, S., El khader, I., Casellas, F., López Vivancos, J., García Cors, M., Santiago, A., Cuenca, S., Guarner, F., & Manichanh, C. (2014). Short-Term Effect of Antibiotics on Human Gut Microbiota. PLoS ONE, 9(4), e95476. https://doi.org/10.1371/journal.pone.0095476
Pinn, D. M., Aroniadis, O. C., & Brandt, L. J. (2014). Is Fecal Microbiota Transplantation the Answer for Irritable Bowel Syndrome? A Single-Center Experience. American Journal of Gastroenterology, 109(11), 1831–1832. https://doi.org/10.1038/ajg.2014.295
Preidis, G.A., Saulnier, D.M., Blutt, S.E., Mistretta, T.-A., Riehle, K.P., Major, A.M., Venable, S.F., Finegold, M.J., Petrosino, J.F., Conner, M.E. and Versalovic, J. (2012). Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 26(5), 1960–1969. https://doi.org/10.1096/fj.10-177980.
Qazi, T., Amaratunga, T., Barnes, E. L., Fischer, M., Kassam, Z., & Allegretti, J. R. (2017). The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis. Gut Microbes, 8(6), 574–588. https://doi.org/10.1080/19490976.2017.1353848
Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V. L., & Cohen, H. (2020). Antibiotics as Major Disruptors of Gut Microbiota. Frontiers in Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.572912
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G., Gasbarrini, A., & Mele, M. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7(1), 14. https://doi.org/10.3390/microorganisms7010014
Sabtu, N., Enoch, D. A., & Brown, N. M. (2015). Antibiotic resistance: what, why, where, when and how? British Medical Bulletin, ldv041. https://doi.org/10.1093/bmb/ldv041
Scheiman, J., Luber, J. M., Chavkin, T. A., MacDonald, T., Tung, A., Pham, L.-D., Wibowo, M. C., Wurth, R. C., Punthambaker, S., Tierney, B. T., Yang, Z., Hattab, M. W., Avila-Pacheco, J., Clish, C. B., Lessard, S., Church, G. M., & Kostic, A. D. (2019). Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nature Medicine, 25(7), 1104–1109. https://doi.org/10.1038/s41591-019-0485-4
Schwan, A. (1983). Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. The Lancet, 322(8354), 845. https://doi.org/10.1016/S0140-6736(83)90753-5
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010). Gut Microbiota in Health and Disease. Physiological Reviews, 90(3), 859–904. https://doi.org/10.1152/physrev.00045.2009
Shreiner, A. B., Kao, J. Y., & Young, V. B. (2015). The gut microbiome in health and in disease. Current Opinion in Gastroenterology, 31(1), 69–75. https://doi.org/10.1097/MOG.0000000000000139
Spencer, C.N., McQuade, J.L., Gopalakrishnan, V., McCulloch, J.A., Vetizou, M., Cogdill, A.P., Khan, M.A.W., Zhang, X., (2021). Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science, 374(6575), 1632-1640. https://doi.org/10.1126/science.aaz7015.
Tariq, R., Pardi, D. S., Tosh, P. K., Walker, R. C., Razonable, R. R., & Khanna, S. (2017a). Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency. Clinical Infectious Diseases, 65(10), 1745–1747. https://doi.org/10.1093/cid/cix618
Tariq, R., Singh, S., Gupta, A., Pardi, D. S., & Khanna, S. (2017b). Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection. JAMA Internal Medicine, 177(6), 784. https://doi.org/10.1001/jamainternmed.2017.0212
Thursby, E., & Juge, N. (2017). Introduction to the human gut microbiota. Biochemical Journal, 474(11), 1823–1836. https://doi.org/10.1042/BCJ20160510
Vindigni, S. M., Zisman, T. L., Suskind, D. L., & Damman, C. J. (2016). The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therapeutic Advances in Gastroenterology, 9(4), 606–625. https://doi.org/10.1177/1756283X16644242
Vrieze, A., Out, C., Fuentes, S., Jonker, L., Reuling, I., Kootte, R. S., van Nood, E., Holleman, F., Knaapen, M., Romijn, J. A., Soeters, M. R., Blaak, E. E., Dallinga-Thie, G. M., Reijnders, D., Ackermans, M. T., Serlie, M. J., Knop, F. K., Holst, J. J., van der Ley, C., … Nieuwdorp, M. (2014). Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. Journal of Hepatology, 60(4), 824–831. https://doi.org/10.1016/j.jhep.2013.11.034
Xie, X., He, Y., Li, H., Yu, D., Na, L., Sun, T., Zhang, D., Shi, X., Xia, Y., Jiang, T., Rong, S., Yang, S., Ma, X., & Xu, G. (2019). Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients. Nutrition, 61, 132–142. https://doi.org/10.1016/j.nut.2018.10.038
Yadav, M., & Chauhan, N. S. (2022). Microbiome therapeutics: exploring the present scenario and challenges. Gastroenterology Report, 10. https://doi.org/10.1093/gastro/goab046
Yang, L., Bajinka, O., Jarju, P. O., Tan, Y., Taal, A. M., & Ozdemir, G. (2021). The varying effects of antibiotics on gut microbiota. AMB Express, 11(1), 116. https://doi.org/10.1186/s13568-021-01274-w
Yassour, M., Vatanen, T., Siljander, H., Hämäläinen, A.-M., Härkönen, T., Ryhänen, S. J., Franzosa, E. A., Vlamakis, H., Huttenhower, C., Gevers, D., Lander, E. S., Knip, M., & Xavier, R. J. (2016). Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Science Translational Medicine, 8(343), 343ra81–343ra81. https://doi.org/10.1126/scitranslmed.aad0917
Zhou, Y., Xu, H., Huang, H., Li, Y., Chen, H., He, J., Du, Y., Chen, Y., Zhou, Y., & Nie, Y. (2019). Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? BioMed Research International, 2019, 1–11. https://doi.org/10.1155/2019/346975Zhou, Y., Xu, H., Huang, H., Li, Y., Chen, H., He, J., Du, Y., Chen, Y., Zhou, Y., & Nie, Y. (2019). Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? BioMed Research International, 2019, 1–11. https://doi.org/10.1155/2019/346975
Copyright (c) 2023 International Academic Publishing House (IAPH)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
